These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 32803568)

  • 1. Worsening of esophageal dilatation is associated with increase in a high-resolution computed tomography (HRCT) score in early systemic sclerosis-associated interstitial lung disease (SSc-ILD).
    Wangkaew S; Losuriya P; Euathrongchit J
    Clin Rheumatol; 2021 Mar; 40(3):955-963. PubMed ID: 32803568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esophageal dilatation and interstitial lung disease in systemic sclerosis: A cross-sectional study.
    Richardson C; Agrawal R; Lee J; Almagor O; Nelson R; Varga J; Cuttica MJ; Dematte JD; Chang RW; Hinchcliff ME
    Semin Arthritis Rheum; 2016 Aug; 46(1):109-14. PubMed ID: 27033049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease.
    Chung JH; Walker CM; Hobbs S
    J Vis Exp; 2020 Jun; (160):. PubMed ID: 32744514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-resolution computed tomographic findings in systemic sclerosis-associated interstitial lung disease: comparison between diffuse and limited systemic sclerosis.
    Patiwetwitoon S; Wangkaew S; Euathrongchit J; Kasitanon N; Louthrenoo W
    J Clin Rheumatol; 2012 Aug; 18(5):229-33. PubMed ID: 22832288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between interstitial lung disease and oesophageal dilatation on chest high-resolution computed tomography in patients with systemic sclerosis: a cross-sectional study.
    Salaffi F; Di Carlo M; Carotti M; Fraticelli P; Gabrielli A; Giovagnoni A
    Radiol Med; 2018 Sep; 123(9):655-663. PubMed ID: 29687210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lung magnetic resonance imaging in systemic sclerosis: a new promising approach to evaluate pulmonary involvement and progression.
    Gargani L; Bruni C; De Marchi D; Romei C; Guiducci S; Bellando-Randone S; Aquaro GD; Pepe A; Neri E; Colagrande S; Falaschi F; Moggi-Pignone A; Pingitore A; Matucci-Cerinic M
    Clin Rheumatol; 2021 May; 40(5):1903-1912. PubMed ID: 33161470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esophageal Dilation and Other Clinical Factors Associated With Pulmonary Function Decline in Patients With Systemic Sclerosis.
    Showalter K; Hoffmann A; Richardson C; Aaby D; Lee J; Dematte J; Agrawal R; Savas H; Wu X; Chang RW; Hinchcliff M
    J Rheumatol; 2021 Dec; 48(12):1830-1838. PubMed ID: 34266985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiographic fibrosis score predicts survival in systemic sclerosis-associated interstitial lung disease.
    Takei R; Arita M; Kumagai S; Ito Y; Tokioka F; Koyama T; Saito R; Nishimura K; Tokumasu H; Ishida T
    Respirology; 2018 Apr; 23(4):385-391. PubMed ID: 28925574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of high-resolution CT-scan in systemic sclerosis-associated interstitial lung disease: Description and prognosis factors.
    Forestier A; Le Gouellec N; Béhal H; Kramer G; Perez T; Sobanski V; Dubois SM; Lambert M; Hatron PY; Hachulla E; Duhamel A; Matran R; Launay D; Rémy-Jardin M
    Semin Arthritis Rheum; 2020 Dec; 50(6):1406-1413. PubMed ID: 32245698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of delta high-resolution computed tomography (HRCT) score with delta clinical variables in early systemic sclerosis (SSc) patients.
    Wangkaew S; Euathrongchit J; Wattanawittawas P; Kasitanon N
    Quant Imaging Med Surg; 2016 Aug; 6(4):381-390. PubMed ID: 27709074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes on chest HRCT in systemic sclerosis-related interstitial lung disease after autologous haematopoietic stem cell transplantation.
    Pugnet G; Petermann A; Collot S; Otal P; Lansiaux P; Ait Abdallah N; Lorillon G; Resche-Rigon M; Borel C; Marjanovic Z; Farge D;
    Rheumatology (Oxford); 2023 Feb; 62(SI):SI32-SI42. PubMed ID: 35686921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KL6 and IL-18 levels are negatively correlated with respiratory function tests and ILD extent assessed on HRCT in patients with systemic sclerosis-related interstitial lung disease (SSc-ILD).
    Sieiro Santos C; Antolín SC; Lorenzo JC; Garay CL; Morales CM; de Miguel EB; Guerrero MR; Herránz LS; Álvarez ED
    Semin Arthritis Rheum; 2024 Apr; 65():152366. PubMed ID: 38290372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of artificial intelligence algorithms to analyse systemic sclerosis-interstitial lung disease imaging features.
    Zhao J; Long Y; Li S; Li X; Zhang Y; Hu J; Han L; Ren L
    Rheumatol Int; 2024 Oct; 44(10):2027-2041. PubMed ID: 39207588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal Changes in Quantitative Interstitial Lung Disease on Computed Tomography after Immunosuppression in the Scleroderma Lung Study II.
    Goldin JG; Kim GHJ; Tseng CH; Volkmann E; Furst D; Clements P; Brown M; Roth M; Khanna D; Tashkin DP
    Ann Am Thorac Soc; 2018 Nov; 15(11):1286-1295. PubMed ID: 30265153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease.
    Suliman YA; Dobrota R; Huscher D; Nguyen-Kim TD; Maurer B; Jordan S; Speich R; Frauenfelder T; Distler O
    Arthritis Rheumatol; 2015 Dec; 67(12):3256-61. PubMed ID: 26316389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal change during follow-up of systemic sclerosis: correlation between high-resolution computed tomography and pulmonary function tests.
    Carnevale A; Silva M; Maietti E; Milanese G; Saracco M; Parisi S; Bravi E; De Gennaro F; Arrigoni E; Bodini FC; Fusaro E; Scirè CA; Sverzellati N; Ariani A
    Clin Rheumatol; 2021 Jan; 40(1):213-219. PubMed ID: 32880053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of interstitial lung disease in systemic sclerosis using the quantitative CT algorithm CALIPER.
    Ferrazza AM; Gigante A; Gasperini ML; Ammendola RM; Paone G; Carbone I; Rosato E
    Clin Rheumatol; 2020 May; 39(5):1537-1542. PubMed ID: 31940114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical algorithms for the diagnosis and prognosis of interstitial lung disease in systemic sclerosis.
    Hax V; Bredemeier M; Didonet Moro AL; Pavan TR; Vieira MV; Pitrez EH; da Silva Chakr RM; Xavier RM
    Semin Arthritis Rheum; 2017 Oct; 47(2):228-234. PubMed ID: 28454677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relevance of high-resolution computed tomographic findings and pulmonary arterial hypertension in systemic sclerosis-associated interstitial lung disease.
    Wangkaew S; Euathrongchit J; Patiwetwitoon S; Prasertwitayakij N; Kasitanon N; Louthrenoo W
    J Med Assoc Thai; 2014 Aug; 97(8):878-85. PubMed ID: 25345265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The predictive role of lung ultrasound in progression of scleroderma interstitial lung disease.
    Gasperini ML; Gigante A; Iacolare A; Pellicano C; Lucci S; Rosato E
    Clin Rheumatol; 2020 Jan; 39(1):119-123. PubMed ID: 31327084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.